Investors in GeneDx, a subsidiary of Sema4 Holdings, are poised for the imminent release of the company’s latest financial results. The market’s focus is squarely on whether the genomic diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results